21784-71-4Relevant articles and documents
Inhibitor daphnetin derivative and application and pharmaceutical composition thereof
-
Paragraph 0048-0056, (2020/11/25)
The invention provides an inhibitor daphnetin derivative and application and a pharmaceutical composition thereof. The daphnetin derivative (1-13) or the pharmaceutically acceptable salt or solvent compound thereof is shown as the following formula. The p
Synthesis and structure-activity relationship of daphnetin derivatives as potent antioxidant agents
Xia, Yangliu,Chen, Chen,Liu, Yong,Ge, Guangbo,Dou, Tongyi,Wang, Ping
, (2018/10/05)
In this study, daphnetin 1 was chosen as the lead compound, and C-3 or C-4-substituted daphnetins were designed and synthesized to explore the potential relationship between the antioxidant activities and the chemical structures of daphnetin derivatives. The antioxidant activities of the generated compounds were evaluated utilizing the free radical scavenging effect on 2,2-diphenyl-1-picrylhydrazyl, 2,2-azinobis-(3-ethylbenzthiazoline-6-sulfonate) cation, and the ferric reducing power assays, and were then compared with those of the standard antioxidant Trolox. The results showed that the catechol group was the key pharmacophore for the antioxidant activity of the daphnetins. The introduction of an electron-withdrawing hydrophilic group at the C-4 position of daphnetin enhanced the antioxidative capacity, but this trend was not observed for C-3 substitution. In addition, introduction of a a hydrophobic phenyl group exerted negative effects on the antioxidant activity in both the C-3 and C-4 substitutions. Among all of the derivatives tested, the most powerful antioxidant was 4-carboxymethyl daphnetin (compound 9), for which the strongest antioxidant activity was observed in all of the assays. In addition, compound 9 also displayed strong pharmaceutical properties in the form of metabolic stability. To summarize, compound 9 holds great potential to be developed as an antioxidant agent with excellent antioxidant activity and proper pharmacokinetic behavior.